Conex (LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION)


Welcome to the PulseAid listing for the Conex drug offered from LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION
NON-PROPRIETARY NAME: Dexbrompheniramine Maleate, Pseudoephedrine HCl
SUBSTANCE NAME: DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2007-11-01
END MARKETING DATE: 0000-00-00


Conex HUMAN OTC DRUG Details:

Item DescriptionConex from LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION
LABELER NAME: LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION
DEA SCHEDULE:
ACTIVE STRENGTH: 2; 60(mg/1; mg/1)
START MARKETING DATE: 2007-11-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54859-702_4ea67627-d9ba-4dc7-9daf-fd8ef0cb9abe
PRODUCT NDC: 54859-702
APPLICATION NUMBER: part341

Other DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ACTIPHARMA, INCACTICON
Actipharma, IncACTICON
Advanced Generic CorporationBIO-CNEX
Llorens Pharmaceutical International DivisionConex
LLORENS PHARMACEUTICALS INTERNATIONAL DIVISIONConex
McLaren MedicalG-Con-X